Business Context and Reporting Period
This Form 8-K is a current report filed by PharmAthene, Inc. (not Altimmune, Inc.) on July 23, 2008. The filing serves as a Regulation FD disclosure to furnish a PowerPoint presentation intended for discussions with stockholders and interested persons.
Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. It explicitly directs readers to the Company's Form 10-K for the year ended December 31, 2007, and Form 10-Q for the quarter ended March 31, 2008, for detailed financial information.
Material Changes
No material changes to financial performance or operations are reported within this specific document. The filing is procedural, designed to distribute a presentation rather than announce new financial results.
Guidance, Outlook, and Risks
The document contains no specific guidance, outlook, or management commentary regarding future performance. It includes a standard caution that the attached presentation should be read in the context of more detailed information in previously filed SEC documents.
Key Facts for Investor Verification
- Verify the correct registrant name is PharmAthene, Inc., as the input metadata incorrectly listed Altimmune, Inc.
- Review the attached Exhibit 99.1 (PowerPoint Presentation) for the actual content intended for investor discussions.
- Consult the Form 10-K (year ended Dec 31, 2007) and Form 10-Q (quarter ended Mar 31, 2008) for the most recent audited and unaudited financial data.
- Note that this filing was signed by David P. Wright, President and CEO, on July 22, 2008.